




📢#FBL-Vol. 29 No. 4 Metastasis and the Microbiome: The Impact of Bacteria in Disseminated #ColorectalCancer 🔓#OpenAccess 🤵: Reed I. Ayabe @ReedAyabe, Michael G. White,* of MD Anderson Cancer Center @MDAndersonNews imrpress.com/journal/FBL/29/… #CELL #CellCancer #Biochemistry

Apply for @MDAndersonNews T32 Research Fellowship "Training of Academic Surgical Oncologists" by Aug. 31! Gain research skills to be an independent surgical investigator in clinical, translational, and lab-based oncology research. Learn more @ bit.ly/3LG3G7l

Finally in print @JCOPO_ASCO! We highlight the role of ctDNA as a prognostic and predictive biomarker in patients with appendix cancer at two high-volume centers ascopubs.org/doi/10.1200/PO.… @ErikaBelmont7 @DavidSuMD @kturaga @jpshen_md @MikeWhiteMD @ArdamanShergil1

A type of bacteria that causes dental plaque is linked to colon cancer and poor treatment responses. Our Dr. Michael White discusses what this discovery means for treating and preventing colon cancer: brnw.ch/21wI6xf @NBCNews @MikeWhiteMD #ColonCancer #EndCancer

Congratulations to our #SSO2024 Clinical Investigator and Young Investigator Research Grant Award winners. We look forward to the impact your work will make on the future of cancer care. @acpmpresearch @cvangelesMD @NGoelMD @MikeWhiteMD @kellykhunt

Warm welcome to our new #BMCSurg Editorial Board Members @amirhsohail from @UNM and @MikeWhiteMD from @MDAndersonNews. We are looking forward to working with you. Interested in joining #BMCSurg? To find out more visit <bmcsurg.biomedcentral.com/jo…>

Men with metastatic #melanoma don't live as long as women, and their tumors are more likely to become resistant to commonly used treatments. A new study may help to explain why. cancer.gov/news-events/cance…

HUGE thanks to patients and scientists, @MDAndersonNews, the melanoma Moon Shots Program, MDA TRACTION, fellow co-firsts @MikeWhiteMD and @RussellGWitt and senior advisors @JenWargoMD, Drs. Heffernan and Marszlek for the vision and guidance at every step of this process! (4/4)

Read together with amazing work by @Moran_Lab (also in this issue of @Nature) also identifying #AR as driver of T-cell exhaustion with #ICB in #CRPC. Together indicative of the huge impact these findings are going to have across #cancer and #treatment types! (3/4)

We looked at 600+ patients and found that females fared better with BRAF/MEKi than males; striking! Dissected this using preclinical models to identify that testosterone-AR promoted resistance and AR blockade improved response to targeted therapy in males…AND females! (2/4)

Beyond excited to share our latest story now published at @Nature which highlights #androgen receptor activity as a key driver of resistance to #BRAF/#MEKi in #melanoma! (1/4) nature.com/articles/s41586-0…

Thrilled to share our work exploring the role of androgens modulating response to BRAF/MEK inhibition. Truly a team effort across @MDAndersonNews and beyond @Moran_Lab! More to come on the role of androgens across cancer types!!! nature.com/articles/s41586-0…

Fantastic presentation by @NassifElise outlining work at @MDAndersonNews as we begin to understand the link between the gut microbiome, tumor immune environment, and response to immunotherapy. @JenWargoMD @CrisyRoland @emilykeungMD #ASCO2022

#Oncologic Components of #HIPEC : Key Question rdcu.be/cNVBV @MikeWhiteMD @MDAndersonNews #VisualAbstract @McMastersKelly

Excited to launch & thanks to teams and trainees @MDAndersonNews Great talks by @AmirJazaeri @emilykeungMD @ShannonWestin @PamSharmaMDPhD @MikeWhiteMD and posters +\- flash talks from @mchelvanambi @GolnazMorad and more! Thx @CrisyRoland @mkatzmd @karenluMD @nadim_ajami and all!
🚀liftoff!!🚀 Congratulations to @CrisyRoland and @JenWargoMD on the Inaugural Transcend Cancer Initiative!Tremendous effort that promises to accelerate translational research to #endcancer @MDAndersonNews @mkatzmd @CDTzeng @HopSTranCao #TCI #oncsurgery